ARID1B and colorectal carcinoma: The results from the short-term proliferation assay and the clonogenic survival assay reveal a significant inhibition of proliferation and clonogenic ability after ARID1B knockdown especially in ARID1A-proficient CRC cell lines, but less in ARID1A-deficient cell lines.